Acquired primary hemostasis pathology detected by platelet function analyzer 200 seen during extracorporeal membrane oxygenation is sufficient to prevent circuit thrombosis: A pilot study

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F20%3A10412685" target="_blank" >RIV/00216208:11130/20:10412685 - isvavai.cz</a>
Alternative codes found
RIV/00064203:_____/20:10412685
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=3MeBWEo2nR" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=3MeBWEo2nR</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.healun.2020.05.015" target="_blank" >10.1016/j.healun.2020.05.015</a>

Result language
angličtina
Original language name
Acquired primary hemostasis pathology detected by platelet function analyzer 200 seen during extracorporeal membrane oxygenation is sufficient to prevent circuit thrombosis: A pilot study
Original language description
Extracorporeal membrane oxygenation (ECMO) used during lung transplantation surgery produces primary hemostasis pathology detected by a platelet function analyzer (PFA) 200. The PFA 200 results return to the pre-operative values soon after ECMO explantation. This phenomenon of primary hemostasis pathology detected by the PFA 200 was successfully used to prevent circuit thrombosis in patients on prolonged ECMO with respiratory or cardiac failure without the use of unfractionated heparin.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30223 - Anaesthesiology

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)